首頁 > 市場調查報告書 > 製藥

疫苗感染疾病

市場調查報告書

商品編碼

1671882

瘧疾疫苗市場：按疫苗類型、按藥劑、按年齡層、按分銷管道、按最終用戶、按地區

Malaria Vaccines Market, By Vaccine Type, By Agent, By Age, By Distribution Channel, By End Users, By Geography

出版日期: 2025年02月06日 | 出版商:

Coherent Market Insights | 英文 166 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球瘧疾疫苗市場規模估計為 6.2 億美元，預計到 2032 年將達到 14.327 億美元，2025 年至 2032 年的複合年成長率為 12.7%。

報告範圍		報告詳細資訊
基準年	2024	2025 年市場規模	6.2億美元
效能資料	2020-2024	預測期	2025-2032
預測期：2025-2032年複合年成長率：	12.70％	2032 年價值預測	14.327億美元

圖。

瘧疾是一種危及生命的疾病，由一種透過受感染的瘧蚊叮咬傳播給人類的寄生蟲所引起。目前可用的瘧疾預防和控制策略，如殺蟲劑處理的蚊帳、殺蟲劑噴灑和抗瘧疾藥，已被證明不足以遏制疾病的傳播。因此，瘧疾疫苗已成為減少瘧疾流行地區發病率和死亡率的迫切且重要的公共衛生工具。疫苗可以提供持久的免疫力，而不需要大規模的醫療保健基礎設施，因此可以為消除瘧疾的目標提供經濟有效且永續的解決方案。

市場動態：

全球瘧疾疫苗市場主要受全球尤其是非洲國家的瘧疾高疾病負擔、全球衛生組織對瘧疾疫苗研發的大量資助以及疫苗作為重要公共衛生干預措施的日益接受所推動。然而，由於瘧疾原蟲的生命週期複雜以及對保護性免疫反應缺乏全面的了解，開發有效的瘧疾疫苗的技術挑戰繼續限制市場潛力。同時，疫苗學、免疫學和病原體基因組學的進步為開發新型疫苗設計方法和抗原標靶創造了機會。此外，世界衛生組織（WHO）、衛生適宜技術規劃署、瘧疾疫苗舉措（PATH MVI）和政府免疫規劃之間的協調努力可以擴大生產能力並成功地將瘧疾疫苗送到當地人群手中。

本研究的主要特點

本報告對全球瘧疾疫苗市場進行了詳細分析，並提供了預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設 2025 年為基準年。

它還強調了各個領域的潛在商機，並說明了該市場的引人注目的投資提案矩陣。

它還提供了關於市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的主要考察。

全球瘧疾疫苗市場的主要企業是根據公司亮點、產品系列、關鍵亮點、業績和策略等參數列出的。

研究涉及的主要企業包括葛蘭素史克公司、Sanaria Inc.、Nobelpharma Co.、Sumaya Biotech、GenVec、默克公司、輝瑞公司、強生公司、Bharat Biotech、印度血清研究所、武田製藥公司、Novavax, Inc.、Inovio Pharmaceuticals、Vaxart, Inc. 和 BioNTech SE。

本報告提供的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球瘧疾疫苗市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。

相關人員將透過用於分析全球瘧疾疫苗市場的各種策略矩陣來做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 620.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	12.70%	2032 Value Projection:	USD 1,432.7 Mn

Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected Anopheles mosquitoes. The currently available strategies for malaria prevention and control such as insecticide treated nets, spraying of insecticides and antimalarial drugs are proving insufficient to curb the spread of the disease. This makes malaria vaccines an urgent and vital public health tool to reduce malaria morbidity and mortality in endemic regions. Vaccines can provide long lasting immunity without requiring large healthcare infrastructure, thereby offering a cost-effective and sustainable solution towards malaria elimination goals.

Market Dynamics:

The global malaria vaccines market is primarily driven by the high disease burden of malaria worldwide, especially in African countries, massive funding for malaria vaccine development from global health organizations and growing acceptance of vaccines as an important public health intervention. However, technical challenges in developing an effective malaria vaccine owing to the complex life cycle of parasite Plasmodium and lack of comprehensive understanding of protective immune responses continue to restrain market potential. Meanwhile, ongoing advancements in vaccinology, immunology, and pathogen genomics have created opportunities for the development of novel vaccine design approaches and antigen targets. Further opportunities lie in expanding manufacturing capacity and ensuring successful uptake of malaria vaccines, once available, in malaria endemic populations through coordinated efforts of World Health Organization (WHO), Program for Appropriate Technology in Health, Malaria Vaccine Initiative (PATH MVI), and government immunization programs.

Key Features of the Study:

This report provides in-depth analysis of the global malaria vaccines market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2025 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global malaria vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include GlaxoSmithKline plc, Sanaria Inc., Nobelpharma Co., Sumaya Biotech, GenVec, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Bharat Biotech, Serum Institute of India, Takeda Pharmaceutical Company, Novavax, Inc., Inovio Pharmaceuticals, Vaxart, Inc., and BioNTech SE

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global malaria vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global malaria vaccines market

Market Segmentation

Vaccine Type Insights (Revenue, USD Mn, 2020 - 2032)
- Pre-Erythrocytic Vaccines
- Erythrocytic Vaccines
- Multi-Antigen Vaccines
Agent Insights (Revenue, USD Mn, 2020 - 2032)
- Plasmodium Falciparum
- Plasmodium Vivax
- Anopheles Species
Age Insights (Revenue, USD Mn, 2020 - 2032)
- Pediatric
- Adult
Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Public
- Private
End Users Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Community Health Centers
- Homecare
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- GlaxoSmithKline plc
- Sanaria Inc.
- Nobelpharma Co.
- Sumaya Biotech
- GenVec
- Merck & Co., Inc.
- Pfizer Inc.
- Johnson & Johnson
- Bharat Biotech
- Serum Institute of India
- Takeda Pharmaceutical Company
- Novavax, Inc.
- Inovio Pharmaceuticals
- Vaxart, Inc.
- BioNTech SE

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Malaria Vaccines Market, By Vaccine Type
- Global Malaria Vaccines Market, By Agent
- Global Malaria Vaccines Market, By Age
- Global Malaria Vaccines Market, By Distribution Channel
- Global Malaria Vaccines Market, By End Users
- Global Malaria Vaccines Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Malaria Vaccines Market, By Vaccine Type, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pre-Erythrocytic Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Erythrocytic Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Multi-Antigen Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Malaria Vaccines Market, By Agent, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Plasmodium Falciparum
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Plasmodium Vivax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Anopheles Species
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Malaria Vaccines Market, By Age, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Malaria Vaccines Market, By Distribution Channel, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Public
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Malaria Vaccines Market, By End Users, 2020-2032, (USD Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Community Health Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
Homecare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Malaria Vaccines Market, By Region, 2020 - 2032, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Agent, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa

10. Competitive Landscape

GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sanaria Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nobelpharma Co.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sumaya Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenVec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Johnson & Johnson
Bharat Biotech
Serum Institute of India
Takeda Pharmaceutical Company
Novavax, Inc.
Inovio Pharmaceuticals
Vaxart, Inc.
BioNTech SE